Vincent M. Lawton
Chairman presso ADDEX THERAPEUTICS LTD
Patrimonio netto: 155 477 $ in data 31/03/2024
Profilo
Dr. Vincent M.
Lawton is an Independent Non-Executive Chairman at Addex Therapeutics Ltd.
and a Chairman at AQIX Ltd.
Dr. Lawton was previously employed as a Non-Executive Director by Medicines & Healthcare Products Regulatory Agency, a President by The Association of the British Pharmaceutical Industry, a Vice President by Merck & Co., Inc., a Managing Director & Vice President by Merck Sharp & Dohme (Europe), Inc., a Founding Member by Ministerial Industry Strategy Group, a Managing Director by Merck Sharp & Dohme Ltd., a Founding Member by Pharmaceutical Industry Competitiveness Task Force, a Founding Member by UK Clinical Research Collaboration, and a Founding Member-Ministerial Industry Strategy by United Kingdom Department of Health & Social Care.
He received his undergraduate degree from the University of London and a doctorate degree from the University of London.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ADDEX THERAPEUTICS LTD
0.79% | 31/12/2022 | 1 464 834 ( 0.79% ) | 155 477 $ | 31/03/2024 |
Posizioni attive di Vincent M. Lawton
| Società | Posizione | Inizio |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Chairman | - |
AQIX Ltd.
 AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Chairman | - |
Precedenti posizioni note di Vincent M. Lawton
| Società | Posizione | Fine |
|---|---|---|
| Medicines & Healthcare Products Regulatory Agency | Director/Board Member | 01/01/2015 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Chief Executive Officer | 01/01/2006 |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | President | 01/01/2006 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2006 |
| Merck Sharp & Dohme (Europe), Inc. | Corporate Officer/Principal | 01/01/2006 |
Formazione di Vincent M. Lawton
| University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ADDEX THERAPEUTICS LTD | Health Technology |
| Aziende private | 9 |
|---|---|
| United Kingdom Department of Health & Social Care | Government |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
AQIX Ltd.
AQIX Ltd. Pharmaceuticals: MajorHealth Technology Aqix Ltd is proud of the affiliations formed with many of its customers and trading partners in an endeavor to bring this unique fluid technology to the biomedical industry on a global scale. Recent events have highlighted the emergence of the company's fluid technology in applications involving stem cell therapy, organ transplant technology, human tissue storage and transportation and preclinical drug bioassay. | Health Technology |
| Merck Sharp & Dohme (Europe), Inc. | |
| Medicines & Healthcare Products Regulatory Agency | Government |
| Pharmaceutical Industry Competitiveness Task Force | Government |
| UK Clinical Research Collaboration | |
| Ministerial Industry Strategy Group |
- Borsa valori
- Insiders
- Vincent M. Lawton
